Summary
81.69 0.93(1.15%)07/02/2024
Arcosa Inc (ACA)
Arcosa Inc (ACA)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 1.15 | -1.41 | -5.29 | -1.74 | -0.41 | 6.91 | 119.25 | 296.81 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 81.69 | |
| Open | 81.02 | |
| High | 81.90 | |
| Low | 80.54 | |
| Volume | 127,884 | |
| Change | 0.93 | |
| Change % | 1.15 | |
| Avg Volume (20 Days) | 203,960 | |
| Volume/Avg Volume (20 Days) Ratio | 0.63 | |
| 52 Week Range | 61.98 - 89.44 | |
| Price vs 52 Week High | -8.67% | |
| Price vs 52 Week Low | 31.80% | |
| Range | 0.83 | |
| Gap Up/Down | -2.83 | |
Fundamentals | ||
| Market Capitalization (Mln) | 3,924 | |
| EBIDTA | 266,700,000 | |
| PE Ratio | 37.4236 | |
| PEG Ratio | 6.7234 | |
| WallStreet Target Price | 66.43 | |
| Book Value | 40.1820 | |
| Earnings Per Share | 1.4400 | |
| EPS Estimate Current Quarter | 0.5000 | |
| EPS Estimate Next Quarter | 0.3800 | |
| EPS Estimate Current Year | 1.7300 | |
| EPS Estimate Next Year | 1.9700 | |
| Diluted EPS (TTM) | 1.4400 | |
| Revenues | ||
| Profit Marging | 0.0359 | |
| Operating Marging (TTM) | 0.0649 | |
| Return on asset (TTM) | 0.0270 | |
| Return on equity (TTM) | 0.0371 | |
| Revenue TTM | 1,973,500,032 | |
| Revenue per share TTM | 41.0500 | |
| Quarterly Revenue Growth (YOY) | 0.1410 | |
| Quarterly Earnings Growth (YOY) | -0.2350 | |
| Gross Profit (TTM) | 382,000,000 | |
| Dividends | ||
| Dividend Share | 0.2000 | |
| Dividend Yield | 0.0037 | |
| Valuations | ||
| Trailing PE | 37.4236 | |
| Forward PE | 22.8311 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 1.3708 | |
| Revenue Enterprise Value | 1.6976 | |
| EBITDA Enterprise Value | 13.7870 | |
| Shares | ||
| Shares Outstanding | 48,329,700 | |
| Shares Float | 47,561,720 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 0.87 | |
| Institutions (%) | 93.45 | |
06/06 13:01 EST - zacks.com
Arcosa (ACA) Upgraded to Strong Buy: Here's What You Should Know
Arcosa (ACA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Arcosa (ACA) Upgraded to Strong Buy: Here's What You Should Know
Arcosa (ACA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
06/06 06:41 EST - zacks.com
Best Value Stocks to Buy for June 6th
ACA, RS and SMFKY made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 6, 2024.
Best Value Stocks to Buy for June 6th
ACA, RS and SMFKY made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 6, 2024.
05/30 06:00 EST - businesswire.com
ACA Group Announces Agreement to Acquire UMB Distribution Services, LLC
NEW YORK--(BUSINESS WIRE)--ACA Group (ACA), the leading provider of governance, risk, and compliance (GRC) solutions to clients in the financial services industry, today announced its intent to acquire the broker-dealer distribution business from UMB Fund Services, a subsidiary of UMB Financial Corporation (Nasdaq: UMBF) (UMB). The transaction is expected to close in the fourth quarter of 2024. ACA's distribution division, ACA Foreside, is the industry's largest third-party distributor by numbe.
ACA Group Announces Agreement to Acquire UMB Distribution Services, LLC
NEW YORK--(BUSINESS WIRE)--ACA Group (ACA), the leading provider of governance, risk, and compliance (GRC) solutions to clients in the financial services industry, today announced its intent to acquire the broker-dealer distribution business from UMB Fund Services, a subsidiary of UMB Financial Corporation (Nasdaq: UMBF) (UMB). The transaction is expected to close in the fourth quarter of 2024. ACA's distribution division, ACA Foreside, is the industry's largest third-party distributor by numbe.
05/22 06:06 EST - zacks.com
Zacks Industry Outlook Owens Corning, Armstrong World Industries, Knife River, Arcosa and Frontdoor
Owens Corning, Armstrong World Industries, Knife River, Arcosa and Frontdoor have been highlighted in this Industry Outlook article.
Zacks Industry Outlook Owens Corning, Armstrong World Industries, Knife River, Arcosa and Frontdoor
Owens Corning, Armstrong World Industries, Knife River, Arcosa and Frontdoor have been highlighted in this Industry Outlook article.
05/21 13:26 EST - zacks.com
Top 5 Stocks to Buy in the Flourishing Building Products Industry
A focus on operational efficiencies, higher government spending and improved residential market raise hopes for OC, AWI, KNF, ACA and FTDR.
Top 5 Stocks to Buy in the Flourishing Building Products Industry
A focus on operational efficiencies, higher government spending and improved residential market raise hopes for OC, AWI, KNF, ACA and FTDR.
05/20 01:36 EST - https://www.defenseworld.net
The Cigna Group (NYSE:CI) and NeueHealth (NYSE:NEUE) Financial Analysis
The Cigna Group (NYSE:CI – Get Free Report) and NeueHealth (NYSE:NEUE – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends. Earnings and Valuation This table compares The Cigna Group and NeueHealth’s gross revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio The Cigna Group $195.27 billion 0.49 $5.16 billion $12.18 27.81 NeueHealth $1.16 billion 0.04 -$1.15 billion ($130.73) -0.05 The Cigna Group has higher revenue and earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than The Cigna Group, indicating that it is currently the more affordable of the two stocks. Profitability This table compares The Cigna Group and NeueHealth’s net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets The Cigna Group 1.76% 17.24% 5.09% NeueHealth -89.78% -5.62% 2.57% Institutional & Insider Ownership 87.0% of The Cigna Group shares are owned by institutional investors. Comparatively, 63.9% of NeueHealth shares are owned by institutional investors. 0.6% of The Cigna Group shares are owned by company insiders. Comparatively, 64.3% of NeueHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Risk and Volatility The Cigna Group has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, NeueHealth has a beta of 0.78, suggesting that its share price is 22% less volatile than the S&P 500. Analyst Ratings This is a summary of current ratings and target prices for The Cigna Group and NeueHealth, as reported by MarketBeat. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score The Cigna Group 0 2 10 1 2.92 NeueHealth 0 1 0 0 2.00 The Cigna Group currently has a consensus price target of $366.14, indicating a potential upside of 8.10%. NeueHealth has a consensus price target of $8.00, indicating a potential upside of 33.56%. Given NeueHealth’s higher probable upside, analysts clearly believe NeueHealth is more favorable than The Cigna Group. Summary The Cigna Group beats NeueHealth on 12 of the 15 factors compared between the two stocks. About The Cigna Group (Get Free Report) The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut. About NeueHealth (Get Free Report) NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
The Cigna Group (NYSE:CI) and NeueHealth (NYSE:NEUE) Financial Analysis
The Cigna Group (NYSE:CI – Get Free Report) and NeueHealth (NYSE:NEUE – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends. Earnings and Valuation This table compares The Cigna Group and NeueHealth’s gross revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio The Cigna Group $195.27 billion 0.49 $5.16 billion $12.18 27.81 NeueHealth $1.16 billion 0.04 -$1.15 billion ($130.73) -0.05 The Cigna Group has higher revenue and earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than The Cigna Group, indicating that it is currently the more affordable of the two stocks. Profitability This table compares The Cigna Group and NeueHealth’s net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets The Cigna Group 1.76% 17.24% 5.09% NeueHealth -89.78% -5.62% 2.57% Institutional & Insider Ownership 87.0% of The Cigna Group shares are owned by institutional investors. Comparatively, 63.9% of NeueHealth shares are owned by institutional investors. 0.6% of The Cigna Group shares are owned by company insiders. Comparatively, 64.3% of NeueHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Risk and Volatility The Cigna Group has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, NeueHealth has a beta of 0.78, suggesting that its share price is 22% less volatile than the S&P 500. Analyst Ratings This is a summary of current ratings and target prices for The Cigna Group and NeueHealth, as reported by MarketBeat. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score The Cigna Group 0 2 10 1 2.92 NeueHealth 0 1 0 0 2.00 The Cigna Group currently has a consensus price target of $366.14, indicating a potential upside of 8.10%. NeueHealth has a consensus price target of $8.00, indicating a potential upside of 33.56%. Given NeueHealth’s higher probable upside, analysts clearly believe NeueHealth is more favorable than The Cigna Group. Summary The Cigna Group beats NeueHealth on 12 of the 15 factors compared between the two stocks. About The Cigna Group (Get Free Report) The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut. About NeueHealth (Get Free Report) NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
05/13 09:40 EST - zacks.com
Arcosa (ACA): Strong Industry, Solid Earnings Estimate Revisions
Arcosa (ACA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Arcosa (ACA): Strong Industry, Solid Earnings Estimate Revisions
Arcosa (ACA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
05/08 10:17 EST - zacks.com
Arcosa, Inc. (ACA) Hit a 52 Week High, Can the Run Continue?
Arcosa (ACA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Arcosa, Inc. (ACA) Hit a 52 Week High, Can the Run Continue?
Arcosa (ACA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
05/06 13:01 EST - zacks.com
All You Need to Know About Arcosa (ACA) Rating Upgrade to Buy
Arcosa (ACA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
All You Need to Know About Arcosa (ACA) Rating Upgrade to Buy
Arcosa (ACA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
05/03 11:38 EST - seekingalpha.com
Arcosa, Inc. (ACA) Q1 2024 Earnings Call Transcript
Arcosa, Inc. (NYSE:ACA ) Q1 2024 Earnings Conference Call April 3, 2024 8:30 AM ET Company Participants Erin Drabek - Director, IR Antonio Carrillo - President and CEO Gail Peck - CFO Conference Call Participants Ian Zaffino - Oppenheimer Brent Thielman - D.A. Davidson Garik Shmois - Loop Capital Markets Trey Grooms - Stephens Operator Good morning, ladies and gentlemen, and welcome to the Arcosa, Inc. First Quarter 2024 Earnings Conference Call.
Arcosa, Inc. (ACA) Q1 2024 Earnings Call Transcript
Arcosa, Inc. (NYSE:ACA ) Q1 2024 Earnings Conference Call April 3, 2024 8:30 AM ET Company Participants Erin Drabek - Director, IR Antonio Carrillo - President and CEO Gail Peck - CFO Conference Call Participants Ian Zaffino - Oppenheimer Brent Thielman - D.A. Davidson Garik Shmois - Loop Capital Markets Trey Grooms - Stephens Operator Good morning, ladies and gentlemen, and welcome to the Arcosa, Inc. First Quarter 2024 Earnings Conference Call.
05/02 18:36 EST - zacks.com
Arcosa (ACA) Q1 Earnings and Revenues Beat Estimates
Arcosa (ACA) came out with quarterly earnings of $0.73 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $1.06 per share a year ago.
Arcosa (ACA) Q1 Earnings and Revenues Beat Estimates
Arcosa (ACA) came out with quarterly earnings of $0.73 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $1.06 per share a year ago.
05/02 16:16 EST - businesswire.com
Arcosa, Inc. Announces First Quarter 2024 Results and Raises Full Year 2024 Guidance
DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our”), a provider of infrastructure-related products and solutions, today announced results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Three Months Ended March 31, 2024 2023 % Change ($ in millions, except per share amounts) Revenues $ 598.6 $ 549.2 9 % Net income $ 39.2 $ 55.7 (30 )% Adjusted Net Income(1)(2) $ 36.0 $ 51.
Arcosa, Inc. Announces First Quarter 2024 Results and Raises Full Year 2024 Guidance
DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our”), a provider of infrastructure-related products and solutions, today announced results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Three Months Ended March 31, 2024 2023 % Change ($ in millions, except per share amounts) Revenues $ 598.6 $ 549.2 9 % Net income $ 39.2 $ 55.7 (30 )% Adjusted Net Income(1)(2) $ 36.0 $ 51.
04/24 16:15 EST - businesswire.com
Arcosa Publishes 2023 Sustainability Report
DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our,”), a provider of infrastructure-related products and solutions, today published its 2023 Sustainability Report, which can be found at www.arcosa.com/sustainability. Overview Our 2023 Sustainability Report highlights foundational elements of the sustainability program at Arcosa. We provide insights into our sustainability strategy, governance structure, and people-focused programs and initiatives at our Co.
Arcosa Publishes 2023 Sustainability Report
DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our,”), a provider of infrastructure-related products and solutions, today published its 2023 Sustainability Report, which can be found at www.arcosa.com/sustainability. Overview Our 2023 Sustainability Report highlights foundational elements of the sustainability program at Arcosa. We provide insights into our sustainability strategy, governance structure, and people-focused programs and initiatives at our Co.
04/18 16:15 EST - businesswire.com
Arcosa, Inc. Announces Timing of First Quarter 2024 Earnings Release and Conference Call
DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, today announced that it will release results for the first quarter ended March 31, 2024 after markets close on Thursday, May 2, 2024. The Company will host an earnings call to discuss the results at 8:30 a.m. Eastern Time on Friday, May 3, 2024. The call can be accessed as follows: Webcast and slide presentation: https://ir.arcosa.com The slides will be a.
Arcosa, Inc. Announces Timing of First Quarter 2024 Earnings Release and Conference Call
DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, today announced that it will release results for the first quarter ended March 31, 2024 after markets close on Thursday, May 2, 2024. The Company will host an earnings call to discuss the results at 8:30 a.m. Eastern Time on Friday, May 3, 2024. The call can be accessed as follows: Webcast and slide presentation: https://ir.arcosa.com The slides will be a.
04/10 13:16 EST - zacks.com
Arcosa (ACA) Buys Ameron, Expands Infrastructure Portfolio
Arcosa (ACA) bolsters its infrastructure solutions through the Ameron acquisition.
Arcosa (ACA) Buys Ameron, Expands Infrastructure Portfolio
Arcosa (ACA) bolsters its infrastructure solutions through the Ameron acquisition.
04/09 16:15 EST - businesswire.com
Arcosa, Inc. Announces Completion of Ameron Acquisition
DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our,”), a provider of infrastructure-related products and solutions, today announced that it has completed the previously announced acquisition of Ameron Pole Products LLC (“Ameron”) from NOV Inc. (NYSE: NOV) for $180 million. Founded in 1970, Ameron is a leading manufacturer of highly engineered, premium concrete and steel poles for a broad range of infrastructure applications, including lighting, traffic, el.
Arcosa, Inc. Announces Completion of Ameron Acquisition
DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our,”), a provider of infrastructure-related products and solutions, today announced that it has completed the previously announced acquisition of Ameron Pole Products LLC (“Ameron”) from NOV Inc. (NYSE: NOV) for $180 million. Founded in 1970, Ameron is a leading manufacturer of highly engineered, premium concrete and steel poles for a broad range of infrastructure applications, including lighting, traffic, el.
04/04 10:36 EST - zacks.com
Should You Invest in Arcosa (ACA) Based on Bullish Wall Street Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Should You Invest in Arcosa (ACA) Based on Bullish Wall Street Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
03/12 13:16 EST - zacks.com
Arcosa (ACA) to Boost Infrastructure Presence With Ameron Buyout
Arcosa (ACA) inks a definitive agreement with NOV Inc to acquire Ameron, aiming to grow in infrastructure markets.
Arcosa (ACA) to Boost Infrastructure Presence With Ameron Buyout
Arcosa (ACA) inks a definitive agreement with NOV Inc to acquire Ameron, aiming to grow in infrastructure markets.
03/11 08:00 EST - businesswire.com
Arcosa Announces Agreement to Acquire Ameron Pole Products from NOV Inc.
DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our,”), a provider of infrastructure-related products and solutions, today announced that it has entered into a definitive agreement to acquire Ameron Pole Products, LLC (“Ameron”) from NOV Inc. (NYSE: NOV) for $180 million in cash. Founded in 1970, Ameron is a leading manufacturer of highly engineered, premium concrete and steel poles for a broad range of infrastructure applications, including lighting, traff.
Arcosa Announces Agreement to Acquire Ameron Pole Products from NOV Inc.
DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our,”), a provider of infrastructure-related products and solutions, today announced that it has entered into a definitive agreement to acquire Ameron Pole Products, LLC (“Ameron”) from NOV Inc. (NYSE: NOV) for $180 million in cash. Founded in 1970, Ameron is a leading manufacturer of highly engineered, premium concrete and steel poles for a broad range of infrastructure applications, including lighting, traff.
03/07 17:35 EST - businesswire.com
Arcosa, Inc. Declares Quarterly Dividend
DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.05 per share on its $0.01 par value common stock. The quarterly cash dividend is payable April 30, 2024 to stockholders of record as of April 15, 2024. About Arcosa Arcosa, Inc. (NYSE: ACA), headquartered in Dallas, Texas, is a provider of infrastructure-related.
Arcosa, Inc. Declares Quarterly Dividend
DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.05 per share on its $0.01 par value common stock. The quarterly cash dividend is payable April 30, 2024 to stockholders of record as of April 15, 2024. About Arcosa Arcosa, Inc. (NYSE: ACA), headquartered in Dallas, Texas, is a provider of infrastructure-related.